Publikationen 2010
Influence of pegvisomant on serum ghrelin and leptin levels in acromegalic patients.
Roemmler J, Otto B, Arafat AM, Bidlingmaier M, Schopohl J.
Eur J Endocrinol. 2010 Nov;163(5):727-34. Epub 2010 Aug 10.
Sun M, Manolopoulou J, Spyroglou A, Beuschlein F, Hantel C, Wu Z, Bielohuby M, Hoeflich A, Liu C, Bidlingmaier M.
Steroids. 2010 Jul 20.
Roemmler J, Steffin B, Gutt B, Schneider HJ, Sievers C, Bidlingmaier M, Schopohl J.
Growth Horm IGF Res. 2010 Jun 30.
Lochmatter D, Strom M, Eblé A, Petkovic V, Flück CE, Bidlingmaier M, Robinson IC, Mullis PE.
Endocrinology. 2010 Jun 30.
Tong J, Prigeon RL, Davis HW, Bidlingmaier M, Kahn SE, Cummings DE, Tschöp MH, D'Alessio D.
Diabetes. 2010 Jun 28.
Progress in primary aldosteronism.
Reincke M, Beuschlein F, Bidlingmaier M, Funder JW, Bornstein SR.
Horm Metab Res. 2010 Jun;42(6):371-3. Epub 2010 May 25.
A Pegylated Growth Hormone Receptor Antagonist, Pegvisomant, Does Not Enter the Brain in Humans.
Veldhuis JD, Bidlingmaier M, Bailey J, Erickson D, Sandroni P.
J Clin Endocrinol Metab. 2010 May 5.
Lacruz ME, Emeny RT, Bickel H, Cramer B, Kurz A, Bidlingmaier M, Huber D, Klug G, Peters A, Ladwig KH.
BMC Med Res Methodol. 2010 Apr 30;10:36.
Morin E, Berthelet F, Weisnagel J, Bidlingmaier M, Serri O.
Pituitary. 2010 Apr 21.
Specific monoclonal antibodies and ultrasensitive immunoassays for 20K and 22K human growth hormone.
Wu Z, Devany E, Balarini G, Junnila R, Bidlingmaier M, Strasburger CJ.
Growth Horm IGF Res. 2010 Mar 19.
Chen WQ, Salmazo A, Myllykoski M, Sjöblom B, Bidlingmaier M, Pollak A, Baumgärtel P, Djinovic-Carugo K, Kursula P, Lubec G.
Amino Acids. 2010 Mar 19. [Epub ahead of print]
Quantification of growth hormone in serum by isotope dilution mass spectrometry.
Arsene CG, Henrion A, Diekmann N, Manolopoulou J, Bidlingmaier M.
Anal Biochem. 2010 Mar 10. [Epub ahead of print]
Morganti A; on behalf of the European study group for the validation of DiaSorin liaison direct renin assay.
J Hypertens. 2010 Mar 10. [Epub ahead of print]
Salivary Aldosterone as a Diagnostic Aid in Primary Aldosteronism.
Manolopoulou J, Gerum S, Mulatero P, Rossignol P, Plouin PF, Reincke M, Bidlingmaier M.
Horm Metab Res. 2010 Mar 9.
Reisch N, Scherr M, Flade L, Bidlingmaier M, Schwarz HP, Müller-Lisse U, Reincke M, Quinkler M, Beuschlein F.
J Clin Endocrinol Metab. 2010 Feb 26.
Detecting growth hormone abuse in athletes.
Bidlingmaier M, Manolopoulou J.
Endocrinol Metab Clin North Am. 2010 Mar;39(1):25-32, vii.
Is Primary Aldosteronism Associated with Diabetes Mellitus? Results of the German Conn's Registry.
Reincke M, Meisinger C, Holle R, Quinkler M, Hahner S, Beuschlein F, Bidlingmaier M, Seissler J, Endres S.
Horm Metab Res. 2010 Jan 29.
Wu S, Walenkamp MJ, Lankester A, Bidlingmaier M, Wit JM, De Luca F.
J Clin Endocrinol Metab. 2010 Jan 15
Bielohuby M, Bodendorf K, Brandstetter H, Bidlingmaier M, Kienzle E.
Br J Nutr. 2010 Jan 5:1-9
Bidlingmaier M, Strasburger CJ.
Handb Exp Pharmacol. 2010;(195):187-200
Endogenous estradiol may influence IGF-I levels in acromegalic women treated with pegvisomant.
Roemmler J, Bidlingmaier M, Schopohl J.
Pituitary. 2010;13(1):89-93.